Deferoxamine and aluminum removal.
D000535:Aluminum / Q000009:adverse effects* / Q000378:metabolism; D001842:Bone and Bones / Q000378:metabolism; D002614:Chelating Agents / Q000627:therapeutic use; D003676:Deferoxamine / Q000378:metabolism / Q000627:therapeutic use*; D003704:Dementia / Q000139:chemically induced; D006801:Humans; D007501:Iron / Q000378:metabolism; D010018:Osteomalacia / Q000139:chemically induced; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis
D002614:Chelating Agents; D000535:Aluminum; D007501:Iron; D003676:Deferoxamine